Reviva Current Ratio from 2010 to 2024
| RVPH Stock | USD 1.37 0.03 2.24% |
Current Ratio | First Reported 2010-12-31 | Previous Quarter 2.82 | Current Value 4.62 | Quarterly Volatility 3.77505796 |
Check Reviva Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Reviva main balance sheet or income statement drivers, such as Interest Expense of 156.3 K, Income Tax Expense of 25.1 K or Tax Provision of 10 K, as well as many exotic indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 6.36. Reviva financial statements analysis is a perfect complement when working with Reviva Pharmaceuticals Valuation or Volatility modules.
Reviva | Current Ratio |
Latest Reviva Pharmaceuticals' Current Ratio Growth Pattern
Below is the plot of the Current Ratio of Reviva Pharmaceuticals Holdings over the last few years. It is a liquidity ratio that measures a company's ability to pay short-term obligations or those due within one year. It compares a firm's current assets to its current liabilities. Reviva Pharmaceuticals' Current Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Reviva Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 6.72 X | 10 Years Trend |
|
Current Ratio |
| Timeline |
Reviva Current Ratio Regression Statistics
| Arithmetic Mean | 2.04 | |
| Geometric Mean | 0 | |
| Coefficient Of Variation | 185.42 | |
| Mean Deviation | 2.71 | |
| Median | 0.000028 | |
| Standard Deviation | 3.78 | |
| Sample Variance | 14.25 | |
| Range | 13.3929 | |
| R-Value | 0.58 | |
| Mean Square Error | 10.10 | |
| R-Squared | 0.34 | |
| Significance | 0.02 | |
| Slope | 0.49 | |
| Total Sum of Squares | 199.51 |
Reviva Current Ratio History
About Reviva Pharmaceuticals Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Reviva Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Reviva Pharmaceuticals investors use historical funamental indicators, such as Reviva Pharmaceuticals's Current Ratio, to determine how well the company is positioned to perform in the future. Although Reviva Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Reviva Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Reviva Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Reviva Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Reviva Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Current Ratio | 2.82 | 4.62 |
Currently Active Assets on Macroaxis
When determining whether Reviva Pharmaceuticals is a strong investment it is important to analyze Reviva Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Reviva Pharmaceuticals' future performance. For an informed investment choice regarding Reviva Stock, refer to the following important reports:Check out the analysis of Reviva Pharmaceuticals Correlation against competitors. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Complementary Tools for Reviva Stock analysis
When running Reviva Pharmaceuticals' price analysis, check to measure Reviva Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reviva Pharmaceuticals is operating at the current time. Most of Reviva Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Reviva Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reviva Pharmaceuticals' price. Additionally, you may evaluate how the addition of Reviva Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
Is Reviva Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Reviva Pharmaceuticals. If investors know Reviva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Reviva Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.43) | Return On Assets (1.16) | Return On Equity (5.56) |
The market value of Reviva Pharmaceuticals is measured differently than its book value, which is the value of Reviva that is recorded on the company's balance sheet. Investors also form their own opinion of Reviva Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Reviva Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Reviva Pharmaceuticals' market value can be influenced by many factors that don't directly affect Reviva Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Reviva Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Reviva Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Reviva Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.